Incidence of synchronous contralateral tonsillar malignancy in a known case of unilateral tonsillar carcinoma
- PMID: 35028695
- DOI: 10.1007/s00405-021-07213-6
Incidence of synchronous contralateral tonsillar malignancy in a known case of unilateral tonsillar carcinoma
Abstract
Objective: The literature is divided with regards to contralateral tonsillectomy in a known/suspected case of ipsilateral tonsillar malignancy. In this study, we evaluate the incidence of indolent synchronous contralateral tonsillar malignancy (SCTC) in patients with known ipsilateral tonsillar malignancy.
Methods: All patients diagnosed with ipsilateral tonsillar carcinoma (TC) at a tertiary teaching center between January 2016 and December 2019 were screened. None of the patients were suspected to have bilateral TC. All patients underwent appropriate imaging in the form of Magnetic resonance imaging and computed tomography of head and neck region and then underwent bilateral tonsillectomy. The prevalence of bilateral tonsillar malignancy and the factors predicting them were analyzed.
Results: In all 59 patients were included in the study. The mean and median age of the patient population was 60.8 and 59 years, respectively, with a male to female ratio of 3.2:1. The incidence of bilateral tonsillar malignancy in carcinoma of unknown primary (CUP) was 3/10 (33.3%). Among the remaining 49 patients, incidence of synchronous contralateral tonsillar carcinoma (SCTC) was 2/49 (4.08%). Overall, 5/59 (8.5%) patients had synchronous bilateral tonsillar malignancy. Furthermore, dysplasia was found in the contralateral tonsil in 4/10 (40%) CUP patients. Among the remaining 49 patients, dysplasia was seen in the contralateral tonsil in 20/49 (40.8%) patients. The absence of p16 expression predicted higher probability of SCTC. Factors like gender, T stage, nodal status or smoking did not predict SCTC.
Conclusion: We recommend bilateral tonsillectomy in all patients with suspected or proven TC (unilateral or bilateral) and CUP as it helps identify indolent SCTC and it does not add any significant morbidity to the patients.
Level of evidence: III.
Keywords: CUP; HPV; Synchronous second primary; Tonsillar malignancy; p16 status.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Beachler DC, D’Souza G (2013) Oral HPV infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol 25(5):503–510 - DOI
-
- Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C (2015) Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol 33(29):3235–3242 - DOI
-
- Cancer Today [Internet]. [cited 2021 Aug 22]. Available from: https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&a...
-
- Slaughter (1953) “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer. Wiley Online Library [Internet]. [cited 2021 Aug 22]. Available from https://acsjournals.onlinelibrary.wiley.com/doi/ https://doi.org/10.1002/1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR28...
-
- Chuang S-C, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV et al (2008) Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 123(10):2390–2396 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
